Methylphenidate Hydrochloride (la)
Product Images NDC 51862-609

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (la) (NDC 51862-609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Methylphenidate 01)

FDA Label Image

Figure 1 (Methylphenidate 02)

FDA Label Image

Figure 2 (Methylphenidate 03)

FDA Label Image

Principal Display Panel (60 mg Capsule Bottle Label)

Principal Display Panel (60 mg Capsule Bottle Label)
Extended-release capsules containing Methylphenidate Hydrochloride, with a strength of UsF..60mg with NDC 51862-614-30. This medication is intended for once-daily use. A medication guide is provided separately for this prescription. Pharmacist to dispense with this information. There are 30 capsules in each bottle.*
FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Principal Display Panel (10 mg Capsule Bottle Label)
Each extended-release capsule contains 10mg of Methylphenidate Hydrochloride. It should be stored in a tight container at a temperature range of 15-30°C (59-86°F). The package insert mentions the usual dosage. The drug has to be kept out of reach of children. The medicine also contains FDBC Yellow No. 6 as a color additive. The medication is manufactured for Mayne Pharma in Greenville, NC. It is necessary to dispense it with the medication guide provided separately.*
FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Principal Display Panel (30 mg Capsule Bottle Label)
This is a prescription medication, Methylphenidate Hydrochloride Extended-Release Capsules (LA), containing 30 mg of methylphenidate hydrochloride per capsule. The medication is dispensed in a tight container and should be stored at temperatures between 15° to 30°C (59° to 86°F). The usual dosage is indicated in the package insert. This medication is manufactured by Mayne Pharma and is for once-daily use only. The pharmacist should dispense with a medication guide provided separately.*
FDA Label Image

Principal Display Panel (40 mg Capsule Bottle Label)

Principal Display Panel (40 mg Capsule Bottle Label)
This is a description of a medication called Methylphenidate Hydrochloride, USP, used for extended-release in capsule form. The capsules include 40mg of the medication and should be kept in a tightly sealed container. Dosages should be based on the prescription and package insert. It is recommended to keep the medication at room temperature, within the range of 15-30°C, and out of reach of children. This medication is manufactured by Mayne Pharma and can be dispensed by a pharmacist with a medication guide provided separately.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.